This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Adverse events associated with hip joint replacement due to fracture
Centers for Medicare & Medicaid Services (CMS), Medicare Patient Safety Monitoring System (MPSMS).
2.35 Percent of patients who had a hip joint replacement due to fracture with adverse events associated with the hip joint replacement, United States, 2002 and 2003.
- CMS, MPSMS, inpatient medical records: for abstracted data related to the index hospital stay.
- CMS Medicare Administrative Data: used for 30-day post-procedure mortality, to identify procedure codes for hip arthroplasty and replacement and to determine 30-day post-procedure readmission.
All patients in the MPSMS sample that experienced a surgical procedure performed to replace a fractured hip joint.
Subset of the denominator who experienced at least 1 of the following:
Postoperative infections, postoperative pneumonia, postoperative urinary tract infection, postoperative deep vein thrombosis or pulmonary embolus, dislocation, wound complications other than infection, nerve injury, postoperative bleeding requiring 4 or more blood transfusions, cardiovascular complications, same side revision during the index hospital stay, return to or for reasons other than same side revision during the index hospital stay, and death.
Postoperative infections are determined by documentation of early prosthetic joint and/or wound infection and acute and early deep hip infection excluding superficial infection.
Postoperative pneumonia, postoperative urinary tract infection, postoperative deep vein thrombosis, and pulmonary embolus are all determined in the same fashion as those in prior MPSMS measures.
Cardiovascular complications include myocardial infarction, congestive heart failure, and arrhythmia requiring treatment.
Wound complications other than infection include dehiscence, hematoma, and necrosis.
In order to attain greater consistency between 2002 and 2003 data, the analytic approach used to produce these tables differs from earlier years of the NHQR.
Return to Contents